CapitolMarkets
Julie Johnson
Julie Johnson
DHouseRepresentative · Texas

Sold up to $15,000 of AbbVie (ABBV)

Trade dated Dec 18, 202528 days to disclose
ABBV since the sale
+1.0%
S&P 500, same window
+11.9%
ABBV trailed the S&P 500 by 11.0 points since the sale

Price move from the trade date's close to the most recent close. A sale is favorable when the stock fell after.

On the public record around this trade

Committee activity, sponsored or cosponsored bills, and floor votes in this sector within 90 days — alongside the trade and its disclosure. Dated public record; draw your own conclusions.

  1. Dec 4, 2025Legislation
    Pharmaceutical sector
  2. Dec 17, 2025Floor vote
    Result: Failed
  3. Dec 17, 2025Floor vote
    Result: Passed
  4. Dec 18, 2025Trade
    Sold up to $15,000 of ABBV
  5. Dec 18, 2025Floor vote
    Result: Failed
  6. Dec 18, 2025Floor vote
    Result: Passed
  7. Jan 15, 2026Legislation
    Pharmaceutical sector
  8. Jan 15, 2026Disclosure
    Disclosed the trade
    Public filing
  9. Jan 21, 2026Legislation
    Pharmaceutical sector
  10. Jan 30, 2026Legislation
    Pharmaceutical sector
  11. Feb 11, 2026Legislation
    Pharmaceutical sector
Source: U.S. House Clerk (disclosures-clerk.house.gov)
Get an alert the moment Julie Johnson files the next one

Capitol Markets tracks every Member of Congress in plain English — the trade, the price move, the committee overlap, the source filing.